ERBB4 and non-small cell lung carcinoma: It could also overpower the metastasis of human NSCLC by suppressing the Erb‐B2 Receptor Tyrosine Kinase 4 (ERBB4)/S6 kinase 2 (S6K2) signaling pathway 19.